173 related articles for article (PubMed ID: 29484193)
1. Serological biomarker testing helps avoiding unnecessary endoscopies in obese patients before bariatric surgery.
Suumann J; Sillakivi T; Riispere Ž; Syrjänen K; Sipponen P; Kirsimägi Ü; Peetsalu A
BMC Obes; 2018; 5():9. PubMed ID: 29484193
[TBL] [Abstract][Full Text] [Related]
2. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Koivurova OP; Koskela R; Blomster T; Ala-Rämi A; Lumme H; Kettunen O; Hukkanen J; Karttunen TJ; Mäkinen M; Ronkainen J; Syrjänen K
Anticancer Res; 2021 Nov; 41(11):5527-5537. PubMed ID: 34732423
[TBL] [Abstract][Full Text] [Related]
3.
MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
5. GastroPanel® Biomarker Assay: The Most Comprehensive Test for
Syrjänen K; Eskelinen M; Peetsalu A; Sillakivi T; Sipponen P; Härkönen M; Paloheimo L; Mäki M; Tiusanen T; Suovaniemi O; DiMARIO F; Fan ZP
Anticancer Res; 2019 Mar; 39(3):1091-1104. PubMed ID: 30842138
[TBL] [Abstract][Full Text] [Related]
6. Serological Biomarker Test (GastroPanel
Paloheimo L; Tiusanen T; Suovaniemi O; SyrjÄnen K
Anticancer Res; 2021 Feb; 41(2):811-819. PubMed ID: 33517286
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive Screening of Autoimmune Atrophic Gastritis in Asymptomatic Subjects by Serological Biomarker Test (GastroPanel
Bakulina N; Tikhonov S; Malkov V; Vorobyev S; Belyakov I; Peshkova N; Belko E; Syrjänen K
Anticancer Res; 2022 Mar; 42(3):1517-1526. PubMed ID: 35220247
[TBL] [Abstract][Full Text] [Related]
8. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
9. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach.
Iijima K; Abe Y; Kikuchi R; Koike T; Ohara S; Sipponen P; Shimosegawa T
World J Gastroenterol; 2009 Feb; 15(7):853-9. PubMed ID: 19230047
[TBL] [Abstract][Full Text] [Related]
10. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
[TBL] [Abstract][Full Text] [Related]
11. A Panel of Serum Biomarkers (GastroPanel®) in Non-invasive Diagnosis of Atrophic Gastritis. Systematic Review and Meta-analysis.
Syrjänen K
Anticancer Res; 2016 Oct; 36(10):5133-5144. PubMed ID: 27798873
[TBL] [Abstract][Full Text] [Related]
12. Value of GastroPanel in the diagnosis of atrophic gastritis.
Grad C; Pop A; Gaborean E; Grad S; Dumitrascu D
Exp Ther Med; 2021 Nov; 22(5):1347. PubMed ID: 34630701
[TBL] [Abstract][Full Text] [Related]
13. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
[TBL] [Abstract][Full Text] [Related]
14. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
15. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
[TBL] [Abstract][Full Text] [Related]
16. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children?
Koivusalo AI; Pakarinen MP; Kolho KL
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782
[TBL] [Abstract][Full Text] [Related]
17. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection: place of serological and cultural diagnostics in clinical guidelines.
Kornoukhova LA; Emanuel VL; Denisov NL; Nikonov EL
Klin Lab Diagn; 2021 Aug; 66(8):496-501. PubMed ID: 34388321
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children.
de Angelis GL; Cavallaro LG; Maffini V; Moussa AM; Fornaroli F; Liatopoulou S; Bizzarri B; Merli R; Comparato G; Caruana P; Cavestro GM; Franzé A; Di Mario F
Dig Dis; 2007; 25(3):206-13. PubMed ID: 17827941
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
